Free Trial

West Pharmaceutical Services (WST) Earnings Date, Estimates & Call Transcripts

$304.31
+5.19 (+1.74%)
(As of 08/21/2024 ET)

Earnings Summary

Upcoming
Earnings Date
Oct. 24Estimated
Actual EPS
(Jul. 25)
$1.52 Missed By -$0.22
Consensus EPS
(Jul. 25)
$1.74
Skip Charts & View Estimated and Actual Earnings Data

WST Earnings Estimates and Actuals by Quarter

The chart below shows up to four years of a company's earnings history. The dark blue line represents the company's actual earnings per share. The light blue area represents the range of Wall Street analysts' earnings estimates for each quarter.

WST Estimated and Actual Revenue by Quarter

The chart below shows up to four years of a company's revenue history. The dark blue line represents the company's actual revenue. The light blue line represents the company's estimated revenue based on the consensus of Wall Street analysts for each quarter.

West Pharmaceutical Services Analyst EPS Estimates

QuarterNumber of EstimatesLow EstimateHigh EstimateAverage EstimateCompany Guidance
Q1 20243$1.30$2.05$1.55 
Q2 20243$1.76$2.28$2.03 
Q3 20243$1.62$2.35$2.05 
Q4 20243$1.83$2.24$2.09 
FY 202412$6.51$8.92$7.72 
Q1 20251$1.65$1.65$1.65 
Q2 20251$1.78$1.78$1.78 
Q3 20251$1.96$1.96$1.96 
Q4 20251$2.12$2.12$2.12 
FY 20254$7.51$7.51$7.51 
Q1 20261$1.87$1.87$1.87 
Q2 20261$2.13$2.13$2.13 

WST Earnings Date and Information

West Pharmaceutical Services last released its quarterly earnings results on July 25th, 2024. The medical instruments supplier reported $1.52 earnings per share (EPS) for the quarter, missing analysts' consensus estimates of $1.74 by $0.22. The business had revenue of $702.10 million for the quarter, compared to the consensus estimate of $729.36 million. Its revenue for the quarter was down 6.9% compared to the same quarter last year. West Pharmaceutical Services has generated $7.58 earnings per share over the last year ($7.58 diluted earnings per share) and currently has a price-to-earnings ratio of 40.1. Earnings for West Pharmaceutical Services are expected to grow by 17.55% in the coming year, from $6.44 to $7.57 per share. West Pharmaceutical Services has not formally confirmed its next earnings publication date, but the company's estimated earnings date is Thursday, October 24th, 2024 based off prior year's report dates.

West Pharmaceutical Services Earnings History by Quarter

DateQuarterConsensus EstimateReported EPSBeat/MissGAAP EPSRevenue EstimateActual RevenueDetails
10/24/2024
(Estimated)
------- 
7/25/2024Q2 2024$1.74$1.52($0.22)$1.53$729.36 million$702.10 million          
4/25/2024Q1 2024$1.29$1.56+$0.27$1.57$670.62 million$695.40 million        
2/15/2024Q4 2023$1.78$1.83+$0.05$1.83$740.43 million$732.00 million          
10/26/2023Q3 2023$1.86$2.16+$0.30$2.18$750.31 million$747.40 million          
7/27/2023Q2 2023$1.95$2.11+$0.16$2.16$755.71 million$753.80 million        
4/27/2023Q1 2023$1.67$1.98+$0.31$2.11$697.28 million$716.60 million        
2/16/2023Q4 2022$1.39$1.77+$0.38$2.18$657.16 million$708.70 million        
10/27/2022Q3 2022$2.12$2.03($0.09)$2.47$730.64 million$686.90 million    
7/28/2022Q2 2022$2.19$2.47+$0.28$2.46$754.25 million$771.30 million        
4/28/2022Q1 2022$2.18$2.30+$0.12$2.31$720.92 million$720.00 million        
2/17/2022Q4 2021$1.92$2.04+$0.12$2.15$710.20 million$730.80 million        
10/28/2021Q3 2021$1.80$2.06+$0.26$1.81$687.09 million$706.50 million        
7/29/2021Q2 2021$1.74$2.46+$0.72$2.45$665.55 million$723.60 million          
4/29/2021Q1 2021$1.42$2.05+$0.63$2.11$614.77 million$670.70 million      
2/18/2021Q4 2020$1.13$1.34+$0.21$1.39$542.07 million$580.20 million    
10/22/2020Q3 2020$0.99$1.15+$0.16$1.21$510.15 million$548.00 million    
7/23/2020Q2 2020$0.91$1.25+$0.34$1.29$496.09 million$527.20 million  
4/23/2020Q1 2020$0.82$1.01+$0.19$1.03$466.79 million$491.50 million  
2/13/2020Q4 2019$0.72$0.82+$0.10$0.80$451.53 million$470.60 million  
10/24/2019Q3 2019$0.71$0.79+$0.08$0.83$450.03 million$456.10 million  

West Pharmaceutical Services Earnings - Frequently Asked Questions

When is West Pharmaceutical Services's earnings date?

West Pharmaceutical Services has not confirmed its next earnings publication date, but the company's estimated earnings date is Thursday, October 24th, 2024 based off last year's report dates. Learn more on WST's earnings history.

What guidance has West Pharmaceutical Services issued on next quarter's earnings?

West Pharmaceutical Services issued an update on its FY 2024 earnings guidance on Thursday, July, 25th. The company provided EPS guidance of 6.350-6.650 for the period, compared to the consensus EPS estimate of 7.740. The company issued revenue guidance of $2.9 billion-$2.9 billion, compared to the consensus revenue estimate of $3.0 billion.

Did West Pharmaceutical Services beat their earnings estimates last quarter?

In the previous quarter, West Pharmaceutical Services (NYSE:WST) missed the analysts' consensus estimate of $1.74 by $0.22 with a reported earnings per share (EPS) of $1.52. Learn more on analysts' earnings estimate vs. WST's actual earnings.

How can I listen to West Pharmaceutical Services's earnings conference call?

The conference call for West Pharmaceutical Services's latest earnings report can be listened to online. Listen to Conference Call

How can I read West Pharmaceutical Services's conference call transcript?

The conference call transcript for West Pharmaceutical Services's latest earnings report can be read online. Read Transcript

How can I view West Pharmaceutical Services's earnings report?

West Pharmaceutical Services's earnings report can be found in their filing with the SEC. View SEC filing

How much revenue does West Pharmaceutical Services generate each year?

West Pharmaceutical Services (NYSE:WST) has a recorded annual revenue of $2.95 billion.

How much profit does West Pharmaceutical Services generate each year?

West Pharmaceutical Services (NYSE:WST) has a recorded net income of $593.40 million. WST has generated $7.58 earnings per share over the last four quarters.

What is West Pharmaceutical Services's price-to-earnings ratio?

West Pharmaceutical Services (NYSE:WST) has a trailing price-to-earnings ratio of 40.15 and a forward price-to-earnings ratio of 47.25. The price/earnings-to-growth ratio is 10.68.

What is West Pharmaceutical Services's EPS forecast for next year?

West Pharmaceutical Services's earnings are expected to grow from $6.44 per share to $7.57 per share in the next year, which is a 17.55% increase.


More Earnings Resources from MarketBeat

This page (NYSE:WST) was last updated on 8/22/2024 by MarketBeat.com Staff

From Our Partners